DORM insider notice: 113 shares via Fidelity on NASDAQ
Rhea-AI Filing Summary
The Form 144 notice records a proposed sale of 113 common shares through Fidelity Brokerage Services LLC on NASDAQ, with an aggregate market value of $17,266.38 and an approximate sale date of 08/13/2025. The filing lists total shares outstanding as 30,534,243, so the proposed sale represents a very small fraction of the company’s outstanding stock. The securities to be sold were acquired by option grants dated 03/02/2022 and 03/02/2023 and payment is listed as cash.
The notice also discloses recent sales by Jeffrey Darby: 2,231 shares sold on 08/11/2025 for $317,597.63 and 9,191 shares sold on 08/12/2025 for $1,365,166.37. Key filing identifiers such as the issuer name and filer CIK are not present in the supplied text.
Positive
- None.
Negative
- None.
Insights
TL;DR: Proposed sale is small in size; recent larger disposals by the same person are disclosed; filings lack some issuer identifiers.
The Form 144 shows a proposed sale of 113 common shares with an aggregate market value of $17,266.38 and lists total outstanding shares of 30,534,243. The shares were acquired via option grants on 03/02/2022 and 03/02/2023 and are to be sold through Fidelity Brokerage Services LLC. The filing also reports prior sales by Jeffrey Darby of 2,231 and 9,191 shares on 08/11/2025 and 08/12/2025, respectively. From an investor materiality perspective, the proposed 113-share sale is de minimis relative to shares outstanding, while the two recent sales provide more context on recent insider activity. The document supplied omits the issuer name and filer CIK, reducing transparency for cross-checking.
TL;DR: Disclosure meets Rule 144 structure but missing issuer/filer identifiers; recent option-originated sales are documented.
The filing documents that the securities to be sold were obtained by stock options and will be paid for in cash, which is relevant when assessing insider selling motives and compliance with Rule 144 mechanics. The signer represents they are not aware of undisclosed material adverse information, and no 10b5-1 plan date is provided in the text. The presence of two sizable sales on consecutive days immediately prior to this notice may be meaningful for governance reviewers, though the absence of the issuer name and filer CIK in the supplied content limits the ability to verify roles, relationships, or additional disclosure obligations from this excerpt alone.